To determine if improved tumor detection using Hexvix® blue-light cystoscopy could lead to improved treatment in patients with bladder cancer
• 146 patients with known or suspected bladder cancer were assessed in this open, comparative, within patient, controlled study • Patients were assessed with standard white light cystoscopy and blue-light cystoscopy 1 hour after Hexvix® instillation • Lesions were mapped and biopsies taken from suspicious areas for assessment by an independent pathologist • Treatment plans were recommended by an independent urologist, blinded to the detection method used, based on biopsy results and medical history according to European Association of Urology bladder cancer guidelines • In order to ensure thorough examination under white light, 2 patients per center were randomized not to undergo further blue light cystoscopy
• Hexvix® blue-light cystoscopy imaging improved overall tumor detection
• 31 patients were found to have no pathologically confirmed tumor 
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